Search results
Showing 91 to 105 of 125 results for thyroid* OR hypothyroid* OR Hyperthyroid* OR goiter
the clinical and cost effectiveness of RAI after total or completion thyroidectomy for people with T2 disease and no adverse...
effectiveness of external beam radiotherapy for people with residual or recurrent thyroid cancer? Any explanatory notes(if applicable)...
Sunitinib for the treatment of gastrointestinal stromal tumours (TA179)
Evidence-based recommendations on sunitinib (Sutent) for treating gastrointestinal stromal tumours in adults.
View recommendations for TA179Show all sections
Evidence-based recommendations on axitinib (Inlyta) for previously treated advanced renal cell carcinoma in adults.
Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis (TA312)
Evidence-based recommendations on alemtuzumab (Lemtrada) for treating highly active relapsing–remitting multiple sclerosis in adults.
Awaiting development [GID-QS10088] Expected publication date: TBC
Percutaneous Laser Ablation (PLA) for benign thyroid nodules
Register an interest in this interventional procedure ...
Awaiting development [GID-TA11531] Expected publication date: TBC
In development [GID-TA11359] Expected publication date: 30 April 2025
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)
Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the
NICE guidance that could generate cost savings.
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
TA928 Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine 19...
Managed access allows patients to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.
patient is having their lithium levels monitored every three months and their thyroid function and renal function monitored every six...